Two decades of immunogenic cell death research: a bibliometric analysis of the 100 most cited publications
Frontiers in Oncology · 22.07.2026 · 16
DOI: 10.3389/fonc.2026.1904609 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 22.07.2026. Verfasst von Li Guan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Suining Central Hospital, Suining, China. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Immunogenic cell death (ICD) represents a pivotal concept linking tumor cell demise with the activation of adaptive antitumor immunity. Since the concept was formalized around 2005, ICD has substantially reshaped research in tumor immunology and cancer therapy. However, bibliometric mapping and structured interpretation of the influential literature that has shaped this field remain limited.
Methods
This bibliometric analysis, supplemented by structured narrative interpretation, used the Web of Science Core Collection and Scopus to identify the 100 most-cited ICD-related publications. Publication characteristics, citation patterns, journals, authors, institutions, countries/regions, and keywords were extracted and standardized. VOSviewer and CiteSpace were employed to construct collaboration networks, perform keyword co-occurrence and clustering analyses, and identify research hotspots and thematic evolution over time.
Results
The top 100 most-cited ICD publications were published between 2005 and 2023. Within this highly cited publication set, more included papers were published after 2011, and the largest number of top-cited publications appeared in 2019. Highly cited studies were dominated by contributions from the United States and Western Europe, particularly France, with strong international collaboration networks. A small core of authors and institutions accounted for a substantial proportion of influential output. Keyword and burst analyses revealed a clear evolution from early work defining ICD hallmarks and antigen presentation mechanisms toward later integration with immunotherapy, nanomedicine, phototherapy, and engineered delivery platforms.
Conclusion
Over the past two decades, ICD research has evolved from conceptual and mechanistic foundations toward a multidisciplinary framework with increasing relevance to tumor immunology, immunotherapy, and combination cancer therapy. Future progress will depend on function-based validation of immunogenicity, microenvironment-aware biomarkers, and rational therapeutic combinations to enhance clinical translatability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Suining Central Hospital, Suining, China.
- Department of Medical Cosmetology, Suining Central Hospital, Suining, China.
- School of Stomatology, Zunyi Medical University, Zunyi, China.
Zitieren
APA
Guan, L., Guo, L., Liu, Y., Bao, S., Chen, M., Luo, J., Zhang, H., & Yang, S. (2026). Two decades of immunogenic cell death research: a bibliometric analysis of the 100 most cited publications. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1904609
Vancouver
Guan L, Guo L, Liu Y, Bao S, Chen M, Luo J, et al. Two decades of immunogenic cell death research: a bibliometric analysis of the 100 most cited publications. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1904609
BibTeX
@article{Guan2026,
author = {Guan, Li and Guo, Lijuan and Liu, Yuqiu and Bao, Shengwei and Chen, Mingyang and Luo, Jia and Zhang, Huan and Yang, Sen},
title = {Two decades of immunogenic cell death research: a bibliometric analysis of the 100 most cited publications},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1904609}
}
EUVIMED